Marketing-authorisation holder · Serbia
Abbvie D.o.o. Beograd
29 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Serbia
29 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 29
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Alphagan®2mg/mL · kapi za oči, rastvor | Brimonidine | Serbia | Authorised | 2025 |
| AQUIPTA®10mg · tableta | Atogepant | Serbia | Authorised | 2025 |
| AQUIPTA®60mg · tableta | Atogepant | Serbia | Authorised | 2025 |
| Ganfort®5mg/mL+300mcg/mL · kapi za oči, rastvor | Timolol, Bimatoprost | Serbia | Authorised | 2023 |
| Humira®40mg/0.4mL · rastvor za injekciju u napunjenom injekcionom penu | Adalimumab | Serbia | Authorised | 2023 |
| Humira®20mg · rastvor za injekciju u napunjenom injekcionom špricu | Adalimumab | Serbia | Authorised | 2024 |
| Humira®80mg · rastvor za injekciju u napunjenom injekcionom penu | Adalimumab | Serbia | Authorised | 2024 |
| Lumigan®0.1mg/mL · kapi za oči, rastvor | Bimatoprost | Serbia | Authorised | 2022 |
| Maviret®100mg+40mg · film tableta | Glecaprevir, Pibrentasvir | Serbia | Authorised | 2024 |
| Maviret®100mg+40mg · film tableta | Glecaprevir, Pibrentasvir | Serbia | Authorised | 2024 |
| Ozurdex®700mcg · intravitrealni implant u aplikatoru | Dexamethasone | Serbia | Authorised | 2023 |
| RINVOQ®45mg · tableta sa produženim oslobađanjem | Upadacitinib | Serbia | Authorised | 2024 |
| RINVOQ®45mg · tableta sa produženim oslobađanjem | Upadacitinib | Serbia | Authorised | 2024 |
| RINVOQ®30mg · tableta sa produženim oslobađanjem | Upadacitinib | Serbia | Authorised | 2024 |
| RINVOQ®30mg · tableta sa produženim oslobađanjem | Upadacitinib | Serbia | Authorised | 2024 |
| RINVOQ®15mg · tableta sa produženim oslobađanjem | Upadacitinib | Serbia | Authorised | 2026 |
| RINVOQ®15mg · tableta sa produženim oslobađanjem | Upadacitinib | Serbia | Authorised | 2026 |
| Sevorane®100% · para za inhalaciju, tečnost | Sevoflurane | Serbia | Authorised | 2023 |
| Skyrizi®75mg · rastvor za injekciju u napunjenom injekcionom špricu | Risankizumab | Serbia | Authorised | 2025 |
| Skyrizi®150mg/mL · rastvor za injekciju u napunjenom injekcionom penu | Risankizumab | Serbia | Authorised | 2023 |
| Venclyxto®100mg · film tableta | Venetoclax | Serbia | Authorised | 2025 |
| Venclyxto®100mg · film tableta | Venetoclax | Serbia | Authorised | 2025 |
| Venclyxto®100mg · film tableta | Venetoclax | Serbia | Authorised | 2025 |
| Venclyxto®50mg · film tableta | Venetoclax | Serbia | Authorised | 2025 |
| Venclyxto®50mg · film tableta | Venetoclax | Serbia | Authorised | 2025 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Serbia | 29 | 29 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.